FDA adcomm votes against Lexicon’s type 1 diabetes and CKD drugnews2024-11-01T03:07:17+00:00November 1st, 2024|Endpoints News|
Federal court backs FDA approval of Jazz sleep drug competitornews2024-10-31T19:16:47+00:00October 31st, 2024|Endpoints News|
Exactech Reports the FDA Clearance of Truliant® Porous 3D Tibial Implant for Knee Replacement Surgerynews2024-10-31T14:41:19+00:00October 31st, 2024|Medical Device News Magazine|
FDA says all versions of Novo’s GLP-1 weight loss drugs are now availablenews2024-10-30T16:54:55+00:00October 30th, 2024|Endpoints News|
Following March inspection, Novo Nordisk’s semaglutide manufacturing facility cited by FDAnews2024-10-29T19:38:06+00:00October 29th, 2024|Endpoints News|
What would RFK Jr. do on healthcare? Trump ally’s FDA plans raise alarmnews2024-10-29T19:21:34+00:00October 29th, 2024|Endpoints News|
FDA again questions Lexicon diabetes drug ahead of adcommnews2024-10-29T18:32:24+00:00October 29th, 2024|Endpoints News|
Novartis expands Scemblix label to first-line CML patientsnews2024-10-29T18:10:50+00:00October 29th, 2024|Endpoints News|
GT Metabolic Solutions Announces FDA Clearance of their GT Metabolic’s MagDI™ Systemnews2024-10-29T14:30:41+00:00October 29th, 2024|Medical Device News Magazine|
GLP-1 compounding pharmacies took center stage at digital health’s biggest conferencenews2024-10-29T13:42:26+00:00October 29th, 2024|Endpoints News|
